Abbott Laboratories' (ABT) CEO Miles White on Q3 2016 Results - Earnings Call Transcript

Oct. 19, 2016 11:53 AM ETAbbott Laboratories (ABT)
SA Transcripts profile picture
SA Transcripts

Abbott Laboratories (NYSE:ABT) Q3 2016 Results Earnings Conference Call October 19, 2016 9:00 AM ET


Scott Leinenweber - Vice President of Investor Relations

Miles White - Chairman of the Board, Chief Executive Officer

Brian Yoor - Chief Financial Officer, Senior Vice President of Finance


Mike Weinstein - JPMorgan

Glenn Novarro - RBC Capital

Matt Taylor - Barclays

Rick Wise - Stifel Nicolaus

Larry Biegelsen - Wells Fargo

Jayson Bedford - Raymond James


Good morning and thank you for standing by. Welcome to Abbott's third quarter 2016 earnings conference call. All participants will be able to listen-only until the question-and-answer portion of this call. [Operator Instructions]. This call is being recorded by Abbott. With the exception of any participant's questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's express written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations.

Scott Leinenweber

Good morning and thank you for joining us. With me today are Miles White, Chairman of the Board and Chief Executive Officer; Tom Freyman, Executive Vice President, Finance and Administration; and Brian Yoor, Senior Vice President, Finance and Chief Financial Officer. Miles will provide opening remarks and Brian will discuss our performance in more detail. Following their comments, Miles, Tom, Brian and I will take your questions.

Before we get started, some statements made today may be forward-looking for purposes of the Securities Litigation Reform Act of 1995, including the expected financial results for 2016. Abbott cautions that these forward-looking statements are subject to the risk and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, Risk Factors, to our

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.